Clinical Trials

General Programme - Clinical Trials

Clinical Studies

The funding instrument within General Programme supports Clinical Trials (phase I or phase II) driven by small- and medium-sized companies (SME). The aim is to reduce the existing finance gap in clinical studies by high attracitve loans-funding.
Owner of programme / investor
Target group SME, Start-up
Topic Life sciences
Type of service Funding, Advice
Förderinstrument C3 E Einzelprojekt - Experimentelle Entwicklung
FFG Unit of organisation General programmes
See allSee less

Clinical Trials within General Programme strengthen the competitiviness of companies based in Austria by funding all transaction costs for the clinical study. Start-ups, small and medium-sized companies (less than 250 employees) are the fund recipients. The funding level is max. € 1,5 million each for relevant study costs by funding with low-intrest loans (duration 5 years). Submission is possible at any time. Special features: The evaluation is carried out throughout the General Programme scoreboard and some additonal guidelines for Clinical Studies funding.  The study has to be carried out by a SME in co-operation with an Austrian clinical partner.